🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety of sIPVs of different d...
Status
Completed
Location
Pizhou City Center for Disease Control and Prevention
Start Date
2016-10
Trial ID
NCT02985320
Treatments Being Tested
The purpose of this study is to select the optimal antigen dosage of the th...
Status
Terminated
Location
CEVAXIN - David
Start Date
2017-06-07
Trial ID
NCT03092791
Treatments Being Tested
The purpose of this study is to evaluate immunogenicity and safety of diffe...
Status
Unknown
Location
Multiple Locations
Start Date
2023-04-01
Trial ID
NCT05457946
Treatments Being Tested
This study is a supplementary study of an already finished randomised, doub...
Status
Completed
Location
Pizhou Center for Disease Control and Prevention
Start Date
2019-07-20
Trial ID
NCT04618783
Treatments Being Tested
This study is a randomized, blinded and controlled phase II study to evalua...
Status
Completed
Location
Jiangsu Provincial Center for Diseases Control and Prevention
Start Date
2017-12-28
Trial ID
NCT03902054
A new inactivated polio vaccine based on attenuated poliovirus strains was ...
Status
Completed
Location
NZOZ Centrum Zdrowia "Błonie"
Start Date
2012-02
Trial ID
NCT01709071
The purpose of the study is to evaluate immunogenicity and safety of three ...
Status
Unknown
Location
Multiple Locations
Start Date
2019-11
Trial ID
NCT04073459
Treatments Being Tested
The purpose of this study is to assess the safety and reactogenicity of 3 d...
Status
Completed
Location
De La Salle Health Sciences Institute- DLSUMC
Start Date
2018-07-31
Trial ID
NCT03566940
The purpose of the study is to evaluate safety and immunogenicity of inacti...
Status
Completed
Location
Research Institute for Tropical Medicine
Start Date
2017-05-31
Trial ID
NCT03169725